ASH Preview: Three Areas To Watch In Hematology-Oncology

Novartis hopes a CAR-T with rapid manufacturing will be a winner, while novel bispecific antibodies in lymphoma and myeloma will make appearances, along with next-generation PI3K and BTK inhibitors.

3-D Rendering Red Blood Cells
ASH 2021 includes a variety of updates in blood cancer studies • Source: Shutterstock

The American Society of Hematology meeting is back for 2021, at least partially, taking place as a hybrid conference online and in person in Atlanta 11-14 December, with a variety of companies showcasing their latest clinical findings in hematological cancers and blood disorders.

Below is a selection of data appearing at this year’s ASH meeting that have been generating buzz among analysts.

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Anticancer

More from Therapeutic Category